Showing 2031-2040 of 6774 results for "".
New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21688/Five Hot Things Patients Are Asking for This Winter
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/five-hot-things-patients-are-asking-for-this-winter/23849/New year, new treatment menu.New in My Practice: Cosmeceuticals/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticalsnew-products-4/23858/Molluscum: Challenges and a Promising Solution
https://practicaldermatology.com/topics/rare-disease/molluscum-challenges-and-a-promising-solution/23532/Molluscum is under-diagnosed and under-treated in the US, but a new treatment could change that.Protect Your Practice from Fraud, Part 2
https://practicaldermatology.com/topics/practice-management/protect-your-practice-from-fraud-part-2/23606/Part 2 of this series reviews common in-office areas of your practice that may be susceptible to fraud and offers tips for protecting yourself and your practice.Teledermatology Two Ways
https://practicaldermatology.com/topics/practice-management/teledermatology-two-ways/20912/As telemedicine grows, dermatology is adapting the practice to benefit patients and physicians.Snapshot: The Percentage of Dermatology Offices Open During the COVID-19 Pandemic
https://practicaldermatology.com/topics/practice-management/snapshot-the-percentage-of-dermatology-offices-open-during-the-covid-19-pandemic/23404/A survey of practices in two states sheds light on the impact of the novel coronavirus.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-35/23723/The State of Prevention in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/the-state-of-prevention-in-atopic-dermatitis/23183/A History of Phlebology: Warts and All, Part 3
https://practicaldermatology.com/topics/practice-management/a-history-of-phlebology-warts-and-all-part-3/20843/